1Yevdokimova N, Wahab NA, Mason RM. Thrombospondin- 1 is the key activator of TGF - betal in human mesangial cells exposed to high glucose. J Am Soc Nephrol,2001,12(4) :703 - 712.
2Hugo CP, Pichler RP, Schulze LE et al .Thrombospondin peptides are potent inhibitors of ~gial and glomerular endothelial cell proliferation in vitro and in vivo. Kidney Int, 1999,55(6) :2 236 - 2 249.
3Chen H, Hemdon ME, Lawler J. The cell biology of thrombospondin- 1. Matrix Biol,2000,19(7) :597 - 614.
4Nesselroth SM, Willis AI, Fuse Set al . The C terminal domain of thrombospin-1 induces vascular smooth muscle cell chemotaxis. J Vase Surg,2001,33(3) :595 - 600.
5Carpizo D, Iruela Arispe ML. Endogenous regulators of angiogenesis emphasison proteins with thrombospondin type 1 motif. Cancer Metastasis Rev,2000,19( 1- 2) : 159 - 165.
6Vailhe B, Feige J. thrombospondin as a therapeutic agent in antiangiogenic therapy. Curr Pharm Des,2003,9(7) :583 - 588.
7Motegi K, Harada K, Pazouki Set al .Evidence of a bi - phasic effect of thrombospondin- 1 on angiogenesis. Histcehem J, 2002, 34(8- 9) :411 - 421.
8Nor JE, Mitra RS, Sutorik MM et al . 3hrombospondin - 1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Rev,2000,37(3):209- 218.
9Jimenez B, Volpert OV, Crawford SEet al .Signals leading to apoptosis dependent inhibition of neovascularization by thrombospondin-1. Nat Med,2000,6(1):41 -48.
10Oldu, Hesketh. The latent transforming growth factor beta binding protein (LTBP) family. Bicehem J,2000,352(3) :601 -610.
